intravenous oxotremorine , oxotremorine-1 , oxotremorine-3 and arecoline dose-dependently decreased ex vivo binding of [ 3h ] oxotremorine-m and correspondingly increased brain ach concentration .
C0006104
brain
C0086045
concentration